Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
Open | $1.560 |
Close | $1.530 |
Volume / Avg. | 32.031K / 91.596K |
Day Range | 1.500 - 1.620 |
52 Wk Range | 0.892 - 2.570 |
Market Cap | $44.222M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.18% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cyclo Therapeutics (NASDAQ: CYTH) through any online brokerage.
Other companies in Cyclo Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Immuneering (NASDAQ:IMRX).
The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by HC Wainwright & Co. on Wednesday, May 1, 2024. The analyst firm set a price target for 3.00 expecting CYTH to rise to within 12 months (a possible 94.81% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $1.54 last updated May 6, 2024 at 9:26 AM EDT.
There are no upcoming dividends for Cyclo Therapeutics.
Cyclo Therapeutics’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for Cyclo Therapeutics.
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.